Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Andriole, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 3:00 p.m. ET.
北卡罗来纳州达勒姆，2024年5月30日（GLOBE NEWSWIRE）——以开发有效改善和延长面临致命疾病的患者寿命的药物为使命的生物制药公司Chimerix（纳斯达克股票代码：CMRX）今天宣布，首席执行官迈克·安德里奥尔将于2024年6月6日星期四下午3点参加杰富瑞全球医疗保健会议的炉边谈话。美国东部时间。
An audio webcast of the panel discussion will be available on the Investor Relations section of Chimerix's website at ir.chimerix.com, where it will be archived for approximately 90 days.
小组讨论的网络音频直播将在Chimerix网站的投资者关系栏目上播出，网址为 ir.chimerix.com，将在那里存档大约 90 天。
About Chimerix
Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company's most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.
关于 Chimerix
Chimerix是一家生物制药公司，其使命是开发能够有效改善和延长面临致命疾病的患者寿命的药物。该公司最先进的临床阶段开发项目 ONC201 正在开发针对 H3 k27M 突变神经胶质瘤。
CONTACT:
联系人：
Will O'Connor
Stern Investor Relations
212-362-1200
will@sternir.com
威尔·奥康纳
斯特恩投资者关系
212-362-1200
will@sternir.com
Source: Chimerix, Inc.
来源：Chimerix, Inc.